Metafolin folate is the biologically active form of the naturally occurring predominant form of folate. It’s well absorbed and its bioavailability is not affected by metabolic variations that prevent a large proportion of the population from efficiently converting traditional folic acid into the metabolically active form needed to deliver a wide range of health benefits.
Folates are water-soluble B vitamins that offer a number of health benefits supported by EFSA-approved health claims. These include Article 13.1 health claims relating to the role folates play in contributing to normal blood formation, cell division, maternal tissue growth during pregnancy, psychological functions, metabolism of the immune system, amino acid synthesis, and can contribute to the reduction of tiredness and fatigue.
Dr Rudolf Moser, managing director at Merck & Cie, Switzerland, said: “Merck actively seeks strategic partnerships to complement and enhance our portfolio. Working with DSM to distribute our innovative L-MTHF product allows us to widen our target markets and bring this innovative product to a larger number of people than ever before.”
“We’re delighted to be working with Merck to bring Metafolin to the market,” said Jacob Bauly, DSM global marketing manager. “Folates are often associated with maternal health. However, this vitamin plays a number of vital roles in the body. Metafolin directly enters the metabolic process and could be an effective and safe alternative to folic acid supplementation. Metafolin allows these people to consume folates and take advantage of the many health benefits they can bring without having to change their lifestyle.”
© FoodBev Media Ltd 2024